Change in agitation in Alzheimer's disease in the placebo arm of a 9-week controlled trial

BACKGROUND: Placebo responses raise significant challenges for design of clinical trials. We report changes in agitation outcomes in the placebo arm of a recent trial of citalopram for agitation in Alzheimer's disease (AD). METHODS: In the Citalopram for Agitation in Alzheimer's Disease (C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int Psychogeriatr
Autori principali: Rosenberg, Paul B., Drye, Lea T., Porsteinsson, Anton P., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Newell, Jeffery, Yesavage, Jerome, Lyketsos, Constantine G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669064/
https://ncbi.nlm.nih.gov/pubmed/26305876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610215001106
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi